• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PTEN和mTOR在骶骨脊索瘤中的表达及其与预后不良的关系。

Expression of PTEN and mTOR in sacral chordoma and association with poor prognosis.

作者信息

Chen Kangwu, Mo Jianqiang, Zhou Ming, Wang Genlin, Wu Guizhong, Chen Hao, Zhang Kai, Yang Huilin

机构信息

Department of Orthopedic Surgery, The First Affiliated Hospital of Soochow University, No. 188 Shizi Street, Suzhou, 215006, Jiangsu, China.

出版信息

Med Oncol. 2014 Apr;31(4):886. doi: 10.1007/s12032-014-0886-7. Epub 2014 Feb 18.

DOI:10.1007/s12032-014-0886-7
PMID:24535608
Abstract

Sacral chordoma is an aggressive, locally invasive neoplasm, and has a poor prognosis. However, the molecular basis for the clinical behavior remains unknown. The purpose of this study was to investigate the expression of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and mammalian target of rapamycin (mTOR) in sacral chordoma, and explore their roles in the prognosis. PTEN and mTOR were detected immunohistochemically in 40 sacral chordoma tissues and 10 adjacent normal tissues. Correlations between PTEN and mTOR expression and clinicopathological factors were analyzed. Kaplan-Meier survival curves and log-rank test were used to analyze the continuous disease-free survival time (CDFS). The expression of PTEN in sacral chordoma was significantly lower than that in adjacent normal tissues, while the levels of mTOR expression in sacral chordoma were significantly higher than that in adjacent normal tissues (P = 0.000, P = 0.030). The positive expression of mTOR appears to correlate with the negative expression of PTEN in sacral chordoma (P = 0.021). PTEN-negative expression and mTOR-positive expression were associated with tumor invasion into the surrounding muscles (P = 0.038, P = 0.014). Log-rank test showed that PTEN-negative and mTOR-positive expressions had an important impact on the patients' CDFS (P = 0.011, P = 0.015). Our results suggest that PTEN and mTOR might play an important role in the local invasiveness of sacral chordoma. PTEN and mTOR might be recognized as important prognostic predictors of recurrence and could be used as potential therapeutic targets for the treatment for sacral chordoma.

摘要

骶骨脊索瘤是一种侵袭性、局部浸润性肿瘤,预后较差。然而,其临床行为的分子基础仍不清楚。本研究旨在探讨10号染色体缺失的磷酸酶和张力蛋白同源物(PTEN)及雷帕霉素哺乳动物靶蛋白(mTOR)在骶骨脊索瘤中的表达,并探讨它们在预后中的作用。采用免疫组织化学方法检测40例骶骨脊索瘤组织和10例相邻正常组织中PTEN和mTOR的表达。分析PTEN和mTOR表达与临床病理因素之间的相关性。采用Kaplan-Meier生存曲线和对数秩检验分析无病生存时间(CDFS)。骶骨脊索瘤中PTEN的表达明显低于相邻正常组织,而骶骨脊索瘤中mTOR的表达水平明显高于相邻正常组织(P = 0.000,P = 0.030)。在骶骨脊索瘤中,mTOR的阳性表达似乎与PTEN的阴性表达相关(P = 0.021)。PTEN阴性表达和mTOR阳性表达与肿瘤侵犯周围肌肉有关(P = 0.038,P = 0.014)。对数秩检验显示,PTEN阴性和mTOR阳性表达对患者的CDFS有重要影响(P = 0.011,P = 0.015)。我们的结果表明,PTEN和mTOR可能在骶骨脊索瘤的局部浸润中起重要作用。PTEN和mTOR可能被认为是复发的重要预后预测指标,并可作为骶骨脊索瘤治疗的潜在治疗靶点。

相似文献

1
Expression of PTEN and mTOR in sacral chordoma and association with poor prognosis.PTEN和mTOR在骶骨脊索瘤中的表达及其与预后不良的关系。
Med Oncol. 2014 Apr;31(4):886. doi: 10.1007/s12032-014-0886-7. Epub 2014 Feb 18.
2
High expression of SPHK1 in sacral chordoma and association with patients' poor prognosis.SPHK1在骶骨脊索瘤中的高表达及其与患者预后不良的关联。
Med Oncol. 2014 Nov;31(11):247. doi: 10.1007/s12032-014-0247-6. Epub 2014 Sep 27.
3
Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma.骨外尤文氏肉瘤中血管内皮生长因子和基质金属蛋白酶-9 的表达。
J Neurooncol. 2011 Feb;101(3):357-63. doi: 10.1007/s11060-010-0263-0. Epub 2010 Jun 15.
4
mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry.实时荧光定量聚合酶链反应和免疫组织化学法检测非小细胞肺癌中 mTOR 和 PTEN 的表达。
Surg Today. 2012 May;42(5):419-25. doi: 10.1007/s00595-011-0028-1. Epub 2011 Nov 30.
5
Overexpression of Raf-1 and ERK1/2 in sacral chordoma and association with tumor recurrence.Raf-1和ERK1/2在骶骨脊索瘤中的过表达及其与肿瘤复发的关系。
Int J Clin Exp Pathol. 2015 Jan 1;8(1):608-14. eCollection 2015.
6
Very rare diseases in oncology.肿瘤学中的罕见疾病。
Med Oncol. 2014 May;31(5):947. doi: 10.1007/s12032-014-0947-y. Epub 2014 Apr 4.
7
Expression of PTEN and mTOR in pancreatic neuroendocrine tumors.PTEN和mTOR在胰腺神经内分泌肿瘤中的表达
Tumour Biol. 2013 Oct;34(5):2871-9. doi: 10.1007/s13277-013-0849-1. Epub 2013 May 19.
8
High expression of survivin in sacral chordoma.在骶骨脊索瘤中生存素高表达。
Med Oncol. 2013 Jun;30(2):529. doi: 10.1007/s12032-013-0529-4. Epub 2013 Mar 16.
9
Expression of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in sacral chordoma.胰岛素样生长因子 II mRNA 结合蛋白 3(IMP3)在骶骨脊索瘤中的表达。
J Neurooncol. 2014 Jan;116(1):77-82. doi: 10.1007/s11060-013-1274-4. Epub 2013 Oct 18.
10
Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization.分析联合栓塞切除骶骨脊索瘤后复发的风险因素。
Spine J. 2009 Dec;9(12):972-80. doi: 10.1016/j.spinee.2009.08.447. Epub 2009 Oct 1.

引用本文的文献

1
KIF15 promotes the development and progression of chordoma via activating PI3K-AKT signalling pathway.驱动蛋白家族成员15(KIF15)通过激活PI3K-AKT信号通路促进脊索瘤的发生发展。
Heliyon. 2024 Apr 9;10(8):e29386. doi: 10.1016/j.heliyon.2024.e29386. eCollection 2024 Apr 30.
2
Expression of mTOR in normal and pathological conditions.mTOR 在正常和病理条件下的表达。
Mol Cancer. 2023 Jul 15;22(1):112. doi: 10.1186/s12943-023-01820-z.
3
Prognostic Relevance and In Vitro Targeting of Concomitant PTEN and p16 Deficiency in Chordomas.

本文引用的文献

1
High expression of survivin in sacral chordoma.在骶骨脊索瘤中生存素高表达。
Med Oncol. 2013 Jun;30(2):529. doi: 10.1007/s12032-013-0529-4. Epub 2013 Mar 16.
2
mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry.实时荧光定量聚合酶链反应和免疫组织化学法检测非小细胞肺癌中 mTOR 和 PTEN 的表达。
Surg Today. 2012 May;42(5):419-25. doi: 10.1007/s00595-011-0028-1. Epub 2011 Nov 30.
3
Immunohistochemical study of PTEN and phosphorylated mTOR proteins in familial and sporadic invasive breast carcinomas.
脊索瘤中PTEN和p16伴随缺失的预后相关性及体外靶向研究
Cancers (Basel). 2023 Mar 26;15(7):1977. doi: 10.3390/cancers15071977.
4
Targeting mTOR Pathway in PTEN Deleted Newly Isolated Chordoma Cell Line.在PTEN缺失的新分离脊索瘤细胞系中靶向mTOR信号通路
J Pers Med. 2023 Feb 27;13(3):425. doi: 10.3390/jpm13030425.
5
Low expression of H3K27me3 is associated with poor prognosis in conventional chordoma.H3K27me3低表达与传统脊索瘤的不良预后相关。
Front Oncol. 2022 Dec 19;12:1048482. doi: 10.3389/fonc.2022.1048482. eCollection 2022.
6
Bibliometric analysis of the global research trends and hotspots in chordoma from 2000 to 2020.2000 年至 2020 年全球 chordoma 研究趋势和热点的文献计量分析。
PLoS One. 2022 Dec 15;17(12):e0279181. doi: 10.1371/journal.pone.0279181. eCollection 2022.
7
Mayo Clinic Clival Chordoma Case Series: Impact of Endoscopic Training on Clinical Care.梅奥诊所斜坡脊索瘤病例系列:内镜培训对临床护理的影响。
Cancers (Basel). 2022 Oct 18;14(20):5104. doi: 10.3390/cancers14205104.
8
PTEN is recognized as a prognostic-related biomarker and inhibits proliferation and invasiveness of skull base chordoma cells.PTEN被认为是一种与预后相关的生物标志物,并能抑制颅底脊索瘤细胞的增殖和侵袭性。
Front Surg. 2022 Sep 23;9:1011845. doi: 10.3389/fsurg.2022.1011845. eCollection 2022.
9
Craniovertebral junction chordomas: Case series and strategies to overcome the surgical challenge.颅颈交界区脊索瘤:病例系列及应对手术挑战的策略
J Craniovertebr Junction Spine. 2021 Oct-Dec;12(4):420-431. doi: 10.4103/jcvjs.jcvjs_87_21. Epub 2021 Dec 11.
10
AZD8055 enhances in vivo efficacy of afatinib in chordomas.AZD8055 增强 afatinib 在软骨肉瘤体内疗效。
J Pathol. 2021 Sep;255(1):72-83. doi: 10.1002/path.5739. Epub 2021 Jul 28.
PTEN 和磷酸化 mTOR 蛋白在家族性和散发性浸润性乳腺癌中的免疫组化研究。
Histopathology. 2010 Jun;56(7):876-82. doi: 10.1111/j.1365-2559.2010.03570.x.
4
Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma.骨外尤文氏肉瘤中血管内皮生长因子和基质金属蛋白酶-9 的表达。
J Neurooncol. 2011 Feb;101(3):357-63. doi: 10.1007/s11060-010-0263-0. Epub 2010 Jun 15.
5
Immunosuppressive cyclosporin A activates AKT in keratinocytes through PTEN suppression: implications in skin carcinogenesis.免疫抑制剂环孢素 A 通过抑制 PTEN 在角质形成细胞中激活 AKT:对皮肤癌发生的影响。
J Biol Chem. 2010 Apr 9;285(15):11369-77. doi: 10.1074/jbc.M109.028142. Epub 2010 Feb 12.
6
Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival.PI3K/mTOR 通路的激活发生在大多数成人低级别胶质瘤中,并预测患者的生存。
J Neurooncol. 2010 Mar;97(1):33-40. doi: 10.1007/s11060-009-0004-4. Epub 2009 Aug 25.
7
Prognostic factors of sacral chordoma after surgical therapy: a study of 36 patients.骶骨脊索瘤手术治疗后的预后因素:36 例研究。
Spinal Cord. 2010 Feb;48(2):166-71. doi: 10.1038/sc.2009.95. Epub 2009 Jul 21.
8
Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordoma.PI3K/mTOR抑制联合疗法在人类脊索瘤中显示出疗效。
Anticancer Res. 2009 Jun;29(6):1867-71.
9
Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway.脊索瘤的潜在治疗靶点:PI3K/AKT/TSC1/TSC2/mTOR通路。
Br J Cancer. 2009 May 5;100(9):1406-14. doi: 10.1038/sj.bjc.6605019.
10
Aberrant hyperactivation of akt and Mammalian target of rapamycin complex 1 signaling in sporadic chordomas.散发性脊索瘤中Akt和哺乳动物雷帕霉素靶蛋白复合物1信号的异常过度激活。
Clin Cancer Res. 2009 Mar 15;15(6):1940-6. doi: 10.1158/1078-0432.CCR-08-2364. Epub 2009 Mar 10.